Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiretroviral Agents”

Showing 20 of 0 results

Not applicableStudy completedNCT02269462
What this trial is testing

Evaluate the Effects of Genetic Factors on the Pharmacokinetics of Antiretroviral Drugs During Pregnancy and Lactation

Who this might be right for
HIVPregnancyBreastfeeding
Adeniyi Olagunju 460
Testing effectiveness (Phase 2)Looking for participantsNCT05419024
What this trial is testing

Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption

Who this might be right for
HIV
National Cancer Institute (NCI) 50
Not applicableStudy completedNCT02055417
What this trial is testing

Increasing Motivation for Antiretroviral Therapy Initiation: A Pilot Intervention

Who this might be right for
HIV
University of Maryland, Baltimore 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT07711210
What this trial is testing

Efficacy and Safety of the ACC017-Based Antiretroviral Regimen in Treatment-Experienced Adults With HIV-1 Harboring Non-Nucleoside Reverse Transcriptase Inhibitor Resistance Mutations

Who this might be right for
Infection, Human Immunodeficiency Virus
Jiangsu Aidea Pharmaceutical Group Co., Ltd. 12
Testing effectiveness (Phase 2)Ended earlyNCT00513513
What this trial is testing

TMC114-C227: A Study to Evaluate the Effectiveness and Safety of TMC114 (Darunavir) With a Low Dose of Ritonavir as Monotherapy (no Other Anti-HIV Drugs Will be Given) in Patients Who Have Never Been Treated With Antiretrovirals (Anti-HIV Drugs) Previously

Who this might be right for
HIV Infections
Tibotec Pharmaceuticals, Ireland 7
Not applicableStudy completedNCT03307226
What this trial is testing

Suubi4Her: Combination Intervention for Adolescent Girls Transitioning Into Adulthood in Uganda

Who this might be right for
HIV/AIDS
Washington University School of Medicine 1,260
Not applicableStudy completedNCT03315013
What this trial is testing

Revised Simplified Algorithm for Treatment Eligibility for HIV (SLATEII)

Who this might be right for
HIV/AIDSAntiretroviral Therapy
Boston University 600
Early research (Phase 1)Study completedNCT00052182
What this trial is testing

Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 40
Not applicableStudy completedNCT02938533
What this trial is testing

Social Norms and Priming to Improve Adherence to Antiretroviral Therapy and Retention in Care

Who this might be right for
HIV InfectionAdherence
University of California, Berkeley 438
Not applicableStudy completedNCT00749840
What this trial is testing

Attitudes and Beliefs and the Steps of HIV Care

Who this might be right for
Human Immunodeficiency Virus Infections
M.D. Anderson Cancer Center 200
Testing effectiveness (Phase 2)Study completedNCT00004578
What this trial is testing

ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects

Who this might be right for
HIV Infections
Abbott 100
Large-scale testing (Phase 3)Study completedNCT00543725
What this trial is testing

TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors

Who this might be right for
HIV InfectionsHIV-1
Tibotec Pharmaceuticals, Ireland 680
Not applicableStudy completedNCT02801747
What this trial is testing

Using MOST to Optimize an HIV Care Continuum Intervention for Vulnerable Populations

Who this might be right for
HIV
New York University 512
Post-approval studies (Phase 4)Study completedNCT01445223
What this trial is testing

A Study on Antiretroviral Therapy (ART) Naïve Patients On Different Regimens to Treat Hiv (NORTHIV)

Who this might be right for
HIV
Göteborg University 242
Not applicableStudy completedNCT00786396
What this trial is testing

Directly Observed Therapy for Community-Released HIV+ Prisoners

Who this might be right for
HIV/AIDSSubstance Abuse
Yale University 151
Testing effectiveness (Phase 2)Study completedNCT02868580
What this trial is testing

Safety and Tolerability of Antiretroviral (Triumeq) in Patients With Amyotrophic Lateral Sclerosis (ALS).

Who this might be right for
Amyotrophic Lateral Sclerosis
Neuroscience Trials Australia 43
Early research (Phase 1)Temporarily pausedNCT06680479
What this trial is testing

Safety and Immunogenicity of Stabilized CH505 TF chTrimer Vaccination in Adults Living With HIV-1 on Suppressive Antiretroviral Therapy

Who this might be right for
HIV-1
National Institute of Allergy and Infectious Diseases (NIAID) 30
Not applicableStudy completedNCT00641641
What this trial is testing

The Effect of Raltegravir on HIV Decay During Primary and Chronic Infection

Who this might be right for
HIV Infection
Kirby Institute 16
Testing effectiveness (Phase 2)Study completedNCT03851588
What this trial is testing

Standard Versus Double Dose Dolutegravir in Patients With HIV-associated Tuberculosis

Who this might be right for
HIV InfectionsTuberculosis
University of Cape Town 108
Not applicableStudy completedNCT01452503
What this trial is testing

Assessing Preference for 3 Female Condoms: A Comparative Evaluation of the PATH Woman's Condom, FC2 and the Reddy 6

Who this might be right for
Contraception
FHI 360 170
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation